Durham-based Atsena Therapeutics has raised $150 million to advance gene therapies for preventing or reversing types of ...

The Charcot-Marie-Tooth Association (CMTA) has announced a $300,000 investment in a groundbreaking gene editing project aimed ...

At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...

Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Gene therapy and gene editing are on the cutting edge of modern biotechnology. Gene therapies are used to correct genetic abnormalities by introducing genetic material at a cellular level and can ...

An R75W mutation in the gap junction β2 (GJB2) gene causes severe fragmentation of gap junction plaques, connecting adjacent ...

Beam Therapeutics Inc. (NASDAQ:BEAM) on Saturday presented additional data from the Phase 1/2 clinical trial of BEAM-302 in ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Cell And Gene Therapy Market Size and ForecastThe global cell and gene therapy market is projected to witness significant ...

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...